Duke has suspended three clinical trials related to the work of Anil Potti, the researcher who apparently claimed, falsely, to have been a Rhodes Scholar on applications for federal grant funding.
The clinical trials all involved cancer treatment, and many of the enrolled patients were from the Triangle area.
The work Potti has done on genetic tests that might predict certain cancers has been called into question before; since the revelation about Potti's false Rhodes claim, Duke is re-examining the science.
The Rhodes issue emerged first in The Cancer Letter, a newsletter that reports on cancer issues. Last week, it published an exhaustive look at Potti's Rhodes claim and questions related to his research.